Clinical Trial Update: Bioequivalence Study of Montelukast 10 mg Tablets [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Montelukast 10 mg tablets has been completed, sponsored by GlaxoSmithKline for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED